Dendritic cells and CCAAT/enhancer binding protein-delta (CEBP?) in neuroinflammation and autoimmunity

点击翻译按钮获取中文摘要

This projects aims to develop new treatments by finding the cells and chemicals that naturally stop inflammation in the central nervous system in diseases like MS. It also aims to test new treatments by delivering them to where this inflammation takes place. This targeted delivery should mean fewer side effects because the rest of the body is not exposed to the treatment. Hopefully this will reduce the impact of these diseases on the community, and reduce side effects for the patient.